RAMP® NT-proBNP Test

RAMP NT-proBNP

The RAMP® NT-proBNP test is an accurate, quantitative and rapid diagnostic test that aids in the diagnosis and assessment of severity in individuals suspected of having congestive heart failure (CHF) and can aid in the risk stratification of patients with heart failure.  The RAMP® NT-proBNP test is ideally suited for point of care testing and laboratory use by healthcare professionals.

Request Info Request Quote
    Leave the box checked if you wish to receive occasional special offer emails, or uncheck it to decline. Don't worry, we won't spam you.

    Leave the box checked if you wish to receive occasional special offer emails, or uncheck it to decline. Don't worry, we won't spam you.

Product Description

The RAMP® NT-proBNP test is an FDA cleared whole blood immunoassay BNP test, with proprietary RAMP technology, which detects the levels of N-terminal prohormone of brain natriuretic peptide in patients with congestive heart failure. This product will help physicians and patients where a traditional BNP test cannot.

MANAGING PATIENTS WITH HEART FAILURE

  • 1 out of 4 patients will be readmitted within 30 days of discharge, the highest rate of readmission of any discharge diagnosis
  • 1 in 5 patients diagnosed with heart failure die within the first year and about half of people who develop heart failure die within 5 years of diagnosis
  • Heart failure often presents with non-specific symptoms and is frequently confused with pneumonia or COPD
  • Heart attacks and Coronary Heart Disease are two of the most expensive conditions to treat.

RAMP NT-proBNP TEST

  • Provides rapid, accurate diagnoses and assessment of congestive heart failure.
  • NT-proBNP is roughly 5 times more stable of a biomarker then BNP
  • Better accuracy in mild heart failure patients because the levels of NT-proBNP are 2-10x higher
  • Standardized to Roche Elecsys Lab Analyzer

RAMP NT-proBNP PUBLICATIONS

  1. Multi-Center Validation of the Response Biomedical Corporation RAMP® NT-proBNP Assay with Comparison to the Roche Diagnostics GmbH Elecsys® proBNP Assay
  2. Evaluation of a Point-of-Care Assay for Cardiac Markers for Patients Suspected of Acute Myocardial Infarction
  3. B-type Natriuretic Peptide During Treatment with Sacubitril/Valsartan: the PARADIGM-HF Trial

The RAMP® 200 Reader

The RAMP® NT-proBNP test

RAMP® NT-proBNP Test Principles

  • Quantitative fluorescent immunoassay
  • Sample: 75 µL EDTA whole blood
  • Time to Result: ~15 minutes
  • Single use test cartridge with barcode defines lot specific calibration
  • Proprietary RAMP® buffer enhances performance
  • A calibrated transfer device is provided with every kit
  • RAMP ratio corrects for sources of analytical variability A calibrated transfer device is provided with every kit

Features & Benefits

  • Rapid, accurate, lab quality results within minutes
  • Full range NT-proBNP measurement
  • Broad reportable range enables continuous clinical assessment following initial diagnosis
  • 24 Hour Technical Support available

PRODUCT DETAILS

You may place order by giving us a call

Catalog Number Description
MDC1105 RAMP® NT-proBNP Test

DOCUMENTATION AND VIDEOS

Brochure

 

 Contact us for detailed product information and pricing.

Contact Us